Towa Pharmaceutical
Employees
Market cap
$1.1b
Enterprise valuation
$2.4b (Public information from Sep 2024)
Share price
JPY3005 4553.T
Kadoma Osaka Prefecture (HQ)
Financials
Estimates*
| JPY | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Revenues | 154.9b | 165.6b | 208.9b | 227.9b | 261.2b | 274.5b | 296.0b |
| % growth | 40 % | 7 % | 26 % | 9 % | 15 % | 5 % | 8 % |
| EBITDA | 31.7b | 31.7b | 27.0b | 37.8b | 39.1b | 41.7b | 42.6b |
| % EBITDA margin | 20 % | 19 % | 13 % | 17 % | 15 % | 15 % | 14 % |
| Profit | 14.0b | 15.9b | 2.2b | 16.2b | 13.3b | 14.3b | 16.0b |
| % profit margin | 9 % | 10 % | 1 % | 7 % | 5 % | 5 % | 5 % |
| EV / revenue | 1.2x | 1.5x | 1.2x | 1.4x | 1.3x | 1.2x | 1.1x |
| EV / EBITDA | 5.7x | 7.8x | 8.9x | 8.4x | 8.5x | 7.9x | 7.5x |
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
| Total Funding | - | ||
Recent News about Towa Pharmaceutical
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
